Sectors we cover

Award winning corporate communications

Life Sciences & Pharmaceuticals

Life Sciences Leaves

Specialist knowledge and communications advice from industry qualified experts and international client experience is key to our Healthcare and Life Sciences offering.

We have advised companies including LiDCO, e-Therapeutics, Surgical Innovations, Syntopix, Retroscreen Virology, Biotie, Partnerships in Care, Ascribe and Medicsight. Our extensive experience covers the broad spectrum of businesses within the sector, from drug discovery research to pharmaceutical development and manufacture, to medical technology and healthcare services.

Abchurch advises publically listed companies and privately funded start-ups; we believe it is never too early to raise your profile within the industry. Improving visibility in the early stages of your company’s development can help you to attract investors and commercial partnerships.

Our transactional experience in the sector includes IPOs and M&A and we have worked with international clients including Biotie, introducing them to the UK biotech & Pharma analyst community. There is a growing interest amongst the City community in international companies in the sector with innovative products and sound financing. Abchurch’s broad client base provides us with the contacts within this market which we use to the benefit of our clients.
The dedicated Life Sciences and Healthcare team at Abchurch has a deep understanding of the sector, knowledge of the trade and investor press and our network of contacts within the analyst and investor communities. We provide results-driven, transparent, structured and cohesive programmes in a fresh, dynamic and strategic approach to external communications.

To contact members of our Life Sciences and Healthcare, see
Adam Michael, Head of Life Sciences.